I don't have any more specific information on the 2 inhalers other than what has previously been mentioned here and elsewhere. Equivalency has been demonstrated in vitro. Dreamboat has the added benefits of being more efficient (less insulin wasted), and it is disposable (thus not needing cleaning). I have no reason to think they will fail to meet criteria in the in vivo study.